Singular Genomics Systems has filed a patent for silicon-containing detectable compounds and their methods of use. The abstract and claim provide limited information, but it suggests that the patent involves a specific compound or salt thereof with a defined formula. GlobalData’s report on Singular Genomics Systems gives a 360-degree view of the company including its patenting strategy. Buy the report here.
According to GlobalData’s company profile on Singular Genomics Systems, DNA polymerase compositions was a key innovation area identified from patents. Singular Genomics Systems's grant share as of September 2023 was 24%. Grant share is based on the ratio of number of grants to total number of patents.
Silicon-containing detectable compounds and their methods of use
A recently filed patent (Publication Number: US20230295437A1) describes a compound or salt thereof with a specific chemical formula. The compound can have various substituents and functional groups, including alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroarylene. The compound can also be a polymer. The patent claims cover different variations of the compound, including specific substitutions and combinations of substituents.
The patent also describes a method for detecting the presence of an agent using the compound. The method involves covalently binding the compound to the agent and exposing it to absorption light. The emission wavelength is then detected to determine the presence of the agent. The agent can be an oligonucleotide, protein, or compound.
Overall, the patent claims cover a compound or salt thereof with a specific chemical formula and various substituents. The compound can be used in a method for detecting the presence of an agent. The patent provides detailed descriptions of the compound and its variations, as well as the method for detection.